IMN || News

FDA approves Viberzi and Xifaxan for IBS

Posted on: 28/05/2015 - 18:42

The Food and Drug Administration has approved Viberzi (eluxadoline) and Xifaxan (rifaximin) to treat irritable bowel syndrome with diarrhea (IBS-D) in adults, the agency announced May 27. Viberzi is...

Field of Interest: Gastroentero...
Type: News Item

Women’s acne mirrors teen acne

Posted on: 28/05/2015 - 18:34

The distribution of acne lesions in adults is similar to that in adolescents, based on data from a prospective study of 374 women aged 25 years and older. “The stereotype of adult female acne being...

Field of Interest: Pulmonology
Type: News Item

Women’s acne mirrors teen acne

Posted on: 28/05/2015 - 18:34

The distribution of acne lesions in adults is similar to that in adolescents, based on data from a prospective study of 374 women aged 25 years and older. “The stereotype of adult female acne being...

Field of Interest: Dermatology
Type: News Item

Automatic counseling failed to improve adolescent acne

Posted on: 27/05/2015 - 16:05

Adding automated counseling to an acne education website had no impact on improving acne severity and quality of life, but it did encourage more patients to begin or maintain an antiacne skin care...

Field of Interest: Dermatology
Type: News Item

DXA screening: You’re doing it wrong

Posted on: 21/05/2015 - 17:35

Dual-energy x-ray absorptiometry to screen for osteoporosis is both underused in women who meet the U.S. Preventive Services Task Force criteria for screening, and overused in low-risk younger women,...

Field of Interest: Pulmonology
Type: News Item

DXA screening: You’re doing it wrong

Posted on: 21/05/2015 - 17:35

Dual-energy x-ray absorptiometry to screen for osteoporosis is both underused in women who meet the U.S. Preventive Services Task Force criteria for screening, and overused in low-risk younger women,...

Field of Interest: Rheumatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness